Lilly reports Phase 3 data showing retatrutide delivered substantial weight loss, reduced knee pain, and improved ...
Over the past decades, engineers have introduced numerous technologies that rely on light and its underlying characteristics.
In addition to ALS, pridopidine is in late-stage clinical development for HD, with Prilenia and Ferrer planning to initiate a confirmatory study in HD designed to confirm pridopidine's effects and ...
As directors push for technology transformation, a new survey reveals a striking confidence gap in risk oversight—especially ...
As of Thursday, December 11, TryHard Holdings Limited’s THH share price has dipped by 6.20%, which has investors questioning ...
Attorneys at Troutman Pepper Locke LLP discuss developments in state laws regulating private equity investments in health ...
Stocks mostly fell Thursday, a day after major indexes neared closing records following the Federal Reserve's decision to cut ...
Despite soaring progress, scientists at AI’s largest gathering say key questions about how models work and how to measure ...
Visceral obesity is associated with increased left ventricular mass and reduced ventricular volumes — suggesting concentric ...
Bill Reh lived with his kidney disease for decades, not needing a transplant until earlier this year. A donor match was found ...
Silverback Digital Marketing has announced a new series of methodological updates to its mobile app development framework, ...
First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback